Charter Research
Lady Lake, Florida 32792
0 studies enrolling now · 18 studies all time
What they study most
Alzheimer Disease, Alzheimer's Disease, Cognitive Decline, Cognitive Dysfunction, Dementia With Lewy Bodies, Dementia, Alzheimer Type, Diabetic Peripheral Neuropathic Pain, Diabetic Peripheral Neuropathy, Early Alzheimer's Disease, Healthy, Lumbosacral Radiculopathy, Memory Disorders
Studies at this site
- A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease — Running, not enrolling
- Study to Evaluate the Safety, Tolerability and Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies — Completed
- A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's Disease — Stopped early
- An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects — Completed
- A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease — Completed
- A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease. — Completed
- Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease — Completed
- Open-label Extension for Phase 3 Clinical Trials of Simufilam — Stopped early
- A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD — Completed
- Identification of Patients With a High Probability of Meeting Eligibility Criteria for an Alzheimer's Disease Clinical Trial (APHELEIA) — Completed
- Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain — Completed
- Efficacy and Safety of ETX-018810 for the Treatment of Diabetic Peripheral Neuropathic Pain — Completed
- A Study to Evaluate the Safety, Tolerability, and Blood Levels of ACU193 in Participants With MCI or Mild AD — Completed
- NE3107 Activity and Safety in Patients With Parkinson's Disease Using Levodopa — Completed
- Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type — Completed
- Study of Azeliragon in Patients With Mild Alzheimer's Disease and Impaired Glucose Tolerance — Stopped early
- A Study to Assess the Safety and Efficacy of a Single Dose of UBX0101 in Patients With Osteoarthritis of the Knee — Completed
- First in Human Study for Safety and Tolerability of AL003. — Completed